Abingdon Health First Half 2025 Earnings: UK£0.007 loss per share (vs UK£0.004 loss in 1H 2024)

Abingdon Health (LON:ABDX) First Half 2025 Results

Key Financial Results

• Revenue: UK£3.09m (up 28% from 1H 2024).
• Net loss: UK£2.52m (loss widened by 109% from 1H 2024).
• UK£0.007 loss per share (further deteriorated from UK£0.004 loss in 1H 2024).

The end of cancer? These 15 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Abingdon Health Earnings Insights

Looking ahead, revenue is forecast to grow 33% p.a. on average during the next 3 years, compared to a 5.9% growth forecast for the Medical Equipment industry in the United Kingdom.

Performance of the British Medical Equipment industry.

The company's shares are down 10% from a week ago.

Risk Analysis

We should say that we've discovered 2 warning signs for Abingdon Health that you should be aware of before investing here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.